Mallinckrodt Plans New Research Facility

Published Online: Wednesday, December 1, 2004

Mallinckrodt's expansion and relocation of its pharmaceutical research and development laboratory operations are under way. The 65,000-sq-ft facility, located on Marshall Road in Webster Groves, St. Louis, Mo, is slated for completion in the spring of 2005. The renovation will allow for a significant increase in Mallinckrodt's pharmaceutical research capabilities in St. Louis. It also represents the health care company's commitment to ongoing development of innovative generic drug products for human use.

A large segment of the research scientists currently working at Mallinckrodt's St. Louis production plant will relocate to the new facility upon its completion. Furthermore, the company anticipates adding 20 to 25 researchers over the next year. When up and running, the facility will house about 100 individuals. The existing St. Louis research facilities will be redesigned to meet the expanding needs of the company's chemical business.

Latest Articles
Diabetes is not a fun condition.
OTC medications can have serious side effects in children if they are not carefully administered.
Patients with asthma can now access Spiriva Respimat with a prescription at pharmacies across the country.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Latest Issues